16 research firms have given Sabra Health Care REIT (NASDAQ: SBRA) shares a rating of ‘hold’. The company has a 1-year average price target of $17 from the brokerages.
On Friday, the firm started from $17.75 in the stock market with the market cap being $3.67B. The lowest in 52 weeks is $5.55 while the highest is $22.55. Their current, quick, and leverage ratio is 0.85, 0.85, and 0.73. Their 50-day rolling average is $16.91 while the 200-day is $15.19.
According to the 5th November report, the company has quarterly EPS earnings of $0.18 that topped the $0.42 consensus estimate by $0.24. Their net margin was 21% with a 3.78% equity return. SBRA is expected to post an EPS of 1.75 for the present year.
Sabra Health Care REIT paid a dividend of $0.30, indicating a $1.20 year-over-year dividend with a 6.76% yield.
Ventures Of SBRA Stock
BidaskClub decreased the rating of the stock to ‘hold’ from ‘buy. 3% Min. Coupon Principal raised their price target to $17 from $14. JMP Securities raised the rating to ‘outperform’ from ‘market perform’ and issued a price aim of $24. Stifel Nicolaus reassigned it to a rating of ‘hold’ and issued a price objective of $15. Smith Citigroup raised the price objective of SBRA stock to $17 from $14.
Mercer Advisors bought a new position in SBRA stock in Q3 and owns a total of $1,611,000 worth of shares. Sei Investments increased their holdings on the company by almost 4.8% in Q3, owning shares priced at $563,000. Van Associates Corp increased it by approximately 23.5% in Q3 and now owns shares priced at $85,000. Brinker Cap. Investments purchased a new stake in Q3, owning $817,000 worth of shares. Hedge funds and institutional investors own 89.73% SBRA stock.